Do analysts rate CURX or CMND?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Curanex Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings & valuation, CURX or CMND?

Curanex Pharmaceuticals is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Curanex Pharmaceuticals N/A N/A -$4.22M -$7.80 N/A Clearmind Medicine N/A N/A -$3.86M -$139.98 N/A

Is CURX or CMND more profitable?

Curanex Pharmaceuticals' return on equity of -82.07% beat Clearmind Medicine's return on equity. Company Net Margins Return on Equity Return on Assets Curanex Pharmaceuticals N/A -82.07% -79.65% Clearmind Medicine N/A -143.79% -88.51%

Do analysts rate CMND or RVPH?

Reviva Pharmaceuticals has a consensus price target of $75.00, suggesting a potential upside of 13,788.89%. Given Reviva Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Reviva Pharmaceuticals is more favorable than Clearmind Medicine. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Reviva Pharmaceuticals 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has stronger earnings & valuation, CMND or RVPH?

Reviva Pharmaceuticals is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Clearmind Medicine N/A N/A -$3.86M -$139.98 N/A Reviva Pharmaceuticals N/A N/A -$19.86M -$1.85 N/A

Is CMND or RVPH more profitable?

Clearmind Medicine's return on equity of -143.79% beat Reviva Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Clearmind Medicine N/A -143.79% -88.51% Reviva Pharmaceuticals N/A -391.58% -119.08%

Does the media refer more to CMND or RVPH?

In the previous week, Clearmind Medicine had 4 more articles in the media than Reviva Pharmaceuticals. MarketBeat recorded 5 mentions for Clearmind Medicine and 1 mentions for Reviva Pharmaceuticals. Clearmind Medicine's average media sentiment score of 0.18 beat Reviva Pharmaceuticals' score of 0.00 indicating that Clearmind Medicine is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clearmind Medicine 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Reviva Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate SNOA or CMND?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonoma Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend CMND or NCNA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 NuCana 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, CMND or NCNA?

NuCana is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Clearmind Medicine N/A N/A -$3.86M -$139.98 N/A NuCana N/A N/A -$38.71M -$3.81 N/A

Is CMND or NCNA more profitable?

NuCana's return on equity of -41.90% beat Clearmind Medicine's return on equity. Company Net Margins Return on Equity Return on Assets Clearmind Medicine N/A -143.79% -88.51% NuCana N/A -41.90% -33.69%

Do analysts recommend ENVB or CMND?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enveric Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings & valuation, ENVB or CMND?

Enveric Biosciences is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Enveric Biosciences N/A N/A -$8.77M -$12.65 N/A Clearmind Medicine N/A N/A -$3.86M -$139.98 N/A

Is ENVB or CMND more profitable?

Clearmind Medicine's return on equity of -143.79% beat Enveric Biosciences' return on equity. Company Net Margins Return on Equity Return on Assets Enveric Biosciences N/A -168.04% -145.95% Clearmind Medicine N/A -143.79% -88.51%

Clearmind Medicine (CMND) Competitors

$1.70 -0.15 (-8.11%)

Closing price 09/3/2026 04:00 PM Eastern

Extended Trading

$1.70 0.00 (0.00%)

As of 04:39 AM Eastern

Compare

CMND vs. CURX, RVPH, SNOA, NCNA, and ENVB

Should you buy Clearmind Medicine stock or one of its competitors? Clearmind Medicine's main competitors and comparable companies include Curanex Pharmaceuticals (CURX), Reviva Pharmaceuticals (RVPH), Sonoma Pharmaceuticals (SNOA), NuCana (NCNA), and Enveric Biosciences (ENVB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Clearmind Medicine compare to Curanex Pharmaceuticals?

Curanex Pharmaceuticals (NASDAQ:CURX) and Clearmind Medicine (NASDAQ:CMND) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation and media sentiment.

Curanex Pharmaceuticals is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Curanex Pharmaceuticals	N/A	N/A	-$4.22M	-$7.80	N/A
Clearmind Medicine	N/A	N/A	-$3.86M	-$139.98	N/A

In the previous week, Clearmind Medicine had 5 more articles in the media than Curanex Pharmaceuticals. MarketBeat recorded 5 mentions for Clearmind Medicine and 0 mentions for Curanex Pharmaceuticals. Clearmind Medicine's average media sentiment score of 0.18 beat Curanex Pharmaceuticals' score of 0.00 indicating that Clearmind Medicine is being referred to more favorably in the news media.

Company	Overall Sentiment
Curanex Pharmaceuticals	Neutral
Clearmind Medicine	Neutral

Curanex Pharmaceuticals' return on equity of -82.07% beat Clearmind Medicine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Curanex Pharmaceuticals	N/A	-82.07%	-79.65%
Clearmind Medicine	N/A	-143.79%	-88.51%

96.1% of Clearmind Medicine shares are owned by institutional investors. 39.7% of Curanex Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Curanex Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Clearmind Medicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Curanex Pharmaceuticals and Clearmind Medicine tied by winning 5 of the 10 factors compared between the two stocks.

How does Clearmind Medicine compare to Reviva Pharmaceuticals?

Clearmind Medicine (NASDAQ:CMND) and Reviva Pharmaceuticals (NASDAQ:RVPH) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk and media sentiment.

Reviva Pharmaceuticals has a consensus price target of $75.00, suggesting a potential upside of 13,788.89%. Given Reviva Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Reviva Pharmaceuticals is more favorable than Clearmind Medicine.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clearmind Medicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Reviva Pharmaceuticals	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Clearmind Medicine had 4 more articles in the media than Reviva Pharmaceuticals. MarketBeat recorded 5 mentions for Clearmind Medicine and 1 mentions for Reviva Pharmaceuticals. Clearmind Medicine's average media sentiment score of 0.18 beat Reviva Pharmaceuticals' score of 0.00 indicating that Clearmind Medicine is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clearmind Medicine	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Reviva Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Clearmind Medicine's return on equity of -143.79% beat Reviva Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clearmind Medicine	N/A	-143.79%	-88.51%
Reviva Pharmaceuticals	N/A	-391.58%	-119.08%

Clearmind Medicine has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market. Comparatively, Reviva Pharmaceuticals has a beta of 0.5, indicating that its stock price is 50% less volatile than the broader market.

Reviva Pharmaceuticals is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clearmind Medicine	N/A	N/A	-$3.86M	-$139.98	N/A
Reviva Pharmaceuticals	N/A	N/A	-$19.86M	-$1.85	N/A

96.1% of Clearmind Medicine shares are held by institutional investors. Comparatively, 63.2% of Reviva Pharmaceuticals shares are held by institutional investors. 8.9% of Reviva Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Clearmind Medicine beats Reviva Pharmaceuticals on 8 of the 13 factors compared between the two stocks.

How does Clearmind Medicine compare to Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals (NASDAQ:SNOA) and Clearmind Medicine (NASDAQ:CMND) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonoma Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Clearmind Medicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Sonoma Pharmaceuticals has a beta of 1.31, meaning that its share price is 31% more volatile than the broader market. Comparatively, Clearmind Medicine has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market.

In the previous week, Clearmind Medicine had 5 more articles in the media than Sonoma Pharmaceuticals. MarketBeat recorded 5 mentions for Clearmind Medicine and 0 mentions for Sonoma Pharmaceuticals. Clearmind Medicine's average media sentiment score of 0.18 beat Sonoma Pharmaceuticals' score of 0.00 indicating that Clearmind Medicine is being referred to more favorably in the news media.

Company	Overall Sentiment
Sonoma Pharmaceuticals	Neutral
Clearmind Medicine	Neutral

Sonoma Pharmaceuticals has higher revenue and earnings than Clearmind Medicine. Sonoma Pharmaceuticals is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonoma Pharmaceuticals	$21.92M	0.29	-$3.17M	-$1.22	N/A
Clearmind Medicine	N/A	N/A	-$3.86M	-$139.98	N/A

2.0% of Sonoma Pharmaceuticals shares are owned by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are owned by institutional investors. 1.0% of Sonoma Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Clearmind Medicine has a net margin of 0.00% compared to Sonoma Pharmaceuticals' net margin of -10.33%. Sonoma Pharmaceuticals' return on equity of -21.41% beat Clearmind Medicine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonoma Pharmaceuticals	-10.33%	-21.41%	-6.08%
Clearmind Medicine	N/A	-143.79%	-88.51%

Summary

Sonoma Pharmaceuticals beats Clearmind Medicine on 8 of the 13 factors compared between the two stocks.

How does Clearmind Medicine compare to NuCana?

Clearmind Medicine (NASDAQ:CMND) and NuCana (NASDAQ:NCNA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Clearmind Medicine has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, NuCana has a beta of 2.23, meaning that its stock price is 123% more volatile than the broader market.

NuCana's return on equity of -41.90% beat Clearmind Medicine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clearmind Medicine	N/A	-143.79%	-88.51%
NuCana	N/A	-41.90%	-33.69%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clearmind Medicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NuCana	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NuCana is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clearmind Medicine	N/A	N/A	-$3.86M	-$139.98	N/A
NuCana	N/A	N/A	-$38.71M	-$3.81	N/A

96.1% of Clearmind Medicine shares are owned by institutional investors. Comparatively, 44.0% of NuCana shares are owned by institutional investors. 31.2% of NuCana shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Clearmind Medicine had 5 more articles in the media than NuCana. MarketBeat recorded 5 mentions for Clearmind Medicine and 0 mentions for NuCana. Clearmind Medicine's average media sentiment score of 0.18 beat NuCana's score of 0.00 indicating that Clearmind Medicine is being referred to more favorably in the media.

Company	Overall Sentiment
Clearmind Medicine	Neutral
NuCana	Neutral

Summary

NuCana beats Clearmind Medicine on 6 of the 11 factors compared between the two stocks.

How does Clearmind Medicine compare to Enveric Biosciences?

Enveric Biosciences (NASDAQ:ENVB) and Clearmind Medicine (NASDAQ:CMND) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation, dividends and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enveric Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Clearmind Medicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Clearmind Medicine's return on equity of -143.79% beat Enveric Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enveric Biosciences	N/A	-168.04%	-145.95%
Clearmind Medicine	N/A	-143.79%	-88.51%

13.8% of Enveric Biosciences shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 2.4% of Enveric Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Enveric Biosciences has a beta of 1.11, suggesting that its stock price is 11% more volatile than the broader market. Comparatively, Clearmind Medicine has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

Enveric Biosciences is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enveric Biosciences	N/A	N/A	-$8.77M	-$12.65	N/A
Clearmind Medicine	N/A	N/A	-$3.86M	-$139.98	N/A

In the previous week, Clearmind Medicine had 5 more articles in the media than Enveric Biosciences. MarketBeat recorded 5 mentions for Clearmind Medicine and 0 mentions for Enveric Biosciences. Clearmind Medicine's average media sentiment score of 0.18 beat Enveric Biosciences' score of 0.00 indicating that Clearmind Medicine is being referred to more favorably in the news media.

Company	Overall Sentiment
Enveric Biosciences	Neutral
Clearmind Medicine	Neutral

Summary

Clearmind Medicine beats Enveric Biosciences on 7 of the 11 factors compared between the two stocks.

Get Clearmind Medicine News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CMND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CMND vs. The Competition

Export

Metric	Clearmind Medicine	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.89M	$12.25B	$7.26B	$12.73B
Dividend Yield	N/A	2.59%	2.53%	8.86%
P/E Ratio	-0.01	787.27	273.29	25.25
Price / Sales	N/A	754.88	623.67	97.64
Price / Cash	N/A	94.80	77.82	52.26
Price / Book	0.12	12.33	12.92	6.14
Net Income	-$3.86M	$2.82B	$3.47B	$349.01M
7 Day Performance	-3.41%	2.60%	0.60%	-0.27%
1 Month Performance	-0.58%	6.96%	5.72%	0.68%
1 Year Performance	-99.59%	9.45%	25.33%	14.84%

Clearmind Medicine Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CMND Clearmind Medicine	1.3844 of 5 stars	$1.70 -8.1%	N/A	-99.6%	$1.89M	N/A	N/A	N/A
CURX Curanex Pharmaceuticals	0.2181 of 5 stars	$4.60 -0.1%	N/A	-96.1%	$7.21M	N/A	N/A	N/A
RVPH Reviva Pharmaceuticals	1.7567 of 5 stars	$0.51 flat	$75.00 +14,751.5%	-94.1%	$6.62M	N/A	N/A	5	News Coverage Gap Down
SNOA Sonoma Pharmaceuticals	0.3852 of 5 stars	$1.37 -0.7%	N/A	-71.4%	$6.61M	$19.53M	N/A	180
NCNA NuCana	0.8599 of 5 stars	$1.50 -2.3%	N/A	-53.0%	$6.22M	N/A	N/A	30

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CMND) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Clearmind Medicine (CMND) Competitors

CMND vs. CURX, RVPH, SNOA, NCNA, and ENVB

How does Clearmind Medicine compare to Curanex Pharmaceuticals?

Summary

How does Clearmind Medicine compare to Reviva Pharmaceuticals?

Summary

How does Clearmind Medicine compare to Sonoma Pharmaceuticals?

Summary

How does Clearmind Medicine compare to NuCana?

Summary

How does Clearmind Medicine compare to Enveric Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CMND vs. The Competition

Clearmind Medicine Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Clearmind Medicine (CMND) Competitors

CMND vs. CURX, RVPH, SNOA, NCNA, and ENVB

How does Clearmind Medicine compare to Curanex Pharmaceuticals?

Which has stronger earnings & valuation, CURX or CMND?

Does the media refer more to CURX or CMND?

Is CURX or CMND more profitable?

Do insiders & institutionals hold more shares of CURX or CMND?

Do analysts rate CURX or CMND?

Summary

How does Clearmind Medicine compare to Reviva Pharmaceuticals?

Do analysts rate CMND or RVPH?

Does the media refer more to CMND or RVPH?

Is CMND or RVPH more profitable?

Which has more volatility and risk, CMND or RVPH?

Which has stronger earnings & valuation, CMND or RVPH?

Do insiders and institutionals have more ownership in CMND or RVPH?

Summary

How does Clearmind Medicine compare to Sonoma Pharmaceuticals?

Do analysts rate SNOA or CMND?

Which has more volatility & risk, SNOA or CMND?

Does the media prefer SNOA or CMND?

Which has stronger valuation & earnings, SNOA or CMND?

Do institutionals & insiders believe in SNOA or CMND?

Is SNOA or CMND more profitable?

Summary

How does Clearmind Medicine compare to NuCana?

Which has more volatility and risk, CMND or NCNA?

Is CMND or NCNA more profitable?

Do analysts recommend CMND or NCNA?

Which has preferable earnings & valuation, CMND or NCNA?

Do insiders and institutionals believe in CMND or NCNA?

Does the media favor CMND or NCNA?

Summary

How does Clearmind Medicine compare to Enveric Biosciences?

Do analysts recommend ENVB or CMND?

Is ENVB or CMND more profitable?

Do insiders & institutionals hold more shares of ENVB or CMND?

Which has more volatility & risk, ENVB or CMND?

Which has higher earnings & valuation, ENVB or CMND?

Does the media prefer ENVB or CMND?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CMND vs. The Competition

Clearmind Medicine Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools